News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
ARCH VENTURE FUND V LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2020 |
SC 13G/A
| ARCH VENTURE FUND V LP has filed a Schedule 13D for – Exit Filing)* Impinj, Inc. |
| 02/14/2019 |
SC 13G/A
| ARCH VENTURE FUND V LP reports a 6.4% stake in Impinj, Inc. |
| 02/02/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/30/2016 |
4/A
| ARCH VENTURE FUND V LP (10% Owner) has filed a Form 4 on IMPINJ INC |
| 07/26/2016 |
4
| ARCH VENTURE FUND V LP (10% Owner) has filed a Form 4 on IMPINJ INC |
| 07/20/2016 |
3
| ARCH VENTURE FUND V LP (10% Owner) has filed a Form 3 on IMPINJ INC |
| 08/03/2011 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/25/2011 |
4
| ARCH VENTURE FUND V LP (10% Owner) has filed a Form 4 on NeurogesX Inc|
Txns:
| Bought 1,744,186 shares
@ $1.65, valued at
$2.9M
Bought 872,093 warrants
@ $1.65, valued at
$1.4M
|
|
| 11/09/2010 |
SC 13G/A
| ARCH VENTURE FUND V LP has filed a Schedule 13D for TRUBION PHARMACEUTICALS, INC. |
| 11/01/2010 |
4
| ARCH VENTURE FUND V LP (10% Owner) has filed a Form 4 on Trubion Pharmaceuticals, Inc|
Txns:
| Sold 2,209,741 shares
@ $0
Sold 14,503 shares
@ $0
Sold 132,802 shares
@ $0 |
|
| 02/11/2008 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 01/04/2008 |
SC 13D/A
| ARCH VENTURE FUND V LP reports a 17.2% stake in NeurogesX, Inc. |
| 12/27/2007 |
4
| ARCH VENTURE PARTNERS V LP (10% Owner) has filed a Form 4 on NeurogesX Inc|
Txns:
| Bought 382,170 shares
@ $6.18, valued at
$2.4M
Bought 114,651 warrants
@ $8.03, valued at
$920.6k
|
|
| 05/16/2007 |
SC 13D
| ARCH VENTURE FUND V LP reports a 20.3% stake in NeurogesX, Inc. |
| 05/09/2007 |
4
| ARCH VENTURE FUND V LP (10% Owner) has filed a Form 4 on NeurogesX Inc|
Txns:
| Converted 1,834,421 shares
@ $0
Converted 11,004 shares
@ $0
Converted 458,903 shares
@ $0
Converted 4,772,668 convertible preferred
@ $0
Converted 5,302,986 convertible preferred
@ $0
Converted 9,943,100 convertible preferred
@ $0
Converted 7,497,552 options to buy
@ $0
Converted 27,312 convertible preferred
@ $0
Converted 30,347 convertible preferred
@ $0
Converted 56,900 convertible preferred
@ $0
Converted 50,520 options to buy
@ $0 |
|
| 05/04/2007 |
4
| ARCH VENTURE FUND V LP (10% Owner) has filed a Form 4 on NeurogesX Inc|
Txns:
| Bought 227,000 shares
@ $11, valued at
$2.5M
|
|
| 02/14/2007 |
SC 13G/A
| ARCH VENTURE FUND V LP has filed a Schedule 13D for Alnylam Pharmaceuticals, Inc. |
| 02/14/2007 |
SC 13G
| ARCH VENTURE FUND V LP reports a 13.4% stake in TRUBION PHARMACEUTICALS, INC. |
| 10/25/2006 |
4
| ARCH VENTURE FUND V LP (10% Owner) has filed a Form 4 on Trubion Pharmaceuticals, Inc|
Txns:
| Converted 2,141,339 shares
@ $0
Converted 14,345 shares
@ $0
Converted 132,802 shares
@ $0
Converted 979,880 convertible preferred
@ $0
Converted 1,161,459 convertible preferred
@ $0
Converted 6,511 convertible preferred
@ $0
Converted 7,834 convertible preferred
@ $0
Converted 61,333 convertible preferred
@ $0
Converted 71,469 convertible preferred
@ $0 |
|
| 10/19/2006 |
4
| ARCH VENTURE FUND V LP (10% Owner) has filed a Form 4 on Trubion Pharmaceuticals, Inc|
Txns:
| Bought 44,640 shares
@ $13, valued at
$580.3k
|
|
| 04/13/2006 |
SC 13D/A
| ARCH VENTURE FUND V LP has filed a Schedule 13D for CYCLACEL PHARMACEUTICALS, INC. |
| 02/14/2006 |
SC 13G/A
| ARCH VENTURE FUND V LP reports a 5.8% stake in ALNYLAM PHARMACEUTICALS, INC. |
| 02/14/2005 |
SC 13G/A
| ARCH VENTURE FUND V LP reports a 9.4% stake in ALNYLAM PHARMACEUTICALS, INC. |
| 11/12/2004 |
SC 13D
| ARCH VENTURE FUND V LP reports a 18.5% stake in XCYTE THERAPIES, INC. |
| 11/02/2004 |
4
| ARCH VENTURE FUND V LP (10% Owner) has filed a Form 4 on XCYTE THERAPIES INC|
Txns:
| Bought 198,661 options to buy
@ $10, valued at
$2M
Bought 1,339 options to buy
@ $10, valued at
$13.4k
|
|
| 06/10/2004 |
SC 13G
| ARCH VENTURE FUND V LP reports a 10.4% stake in ALNYLAM PHARMACEUTICALS, INC. |
| 03/22/2004 |
4
| ARCH VENTURE FUND V LP (10% Owner) has filed a Form 4 on XCYTE THERAPIES INC|
Txns:
| Converted 212,008 shares
@ $0
Converted 1,654,763 shares
@ $0
Bought 137,500 shares
@ $8, valued at
$1.1M
Bought 50,000 shares
@ $8, valued at
$400k
Converted 212,008 convertible notes
@ $0
Converted 789,469 convertible preferred
@ $0
Converted 2,045,454 convertible preferred
@ $0
Converted 1,119,265 convertible preferred
@ $0
Converted 1,321,942 convertible preferred
@ $0
Converted 935,251 convertible preferred
@ $0
Converted 50,237 options to buy
@ $0 |
|
|
|